Healthcare -
Biotechnology - NASDAQ - US
$ 0.5265
-0.66 %
$ 37.4 M
Market Cap
-1.14
P/E
OVID - CAPITAL EXPENDITURES
Capital Expenditures OVID - Ovid Therapeutics Inc.
-137 K
LAST VALUE
14.81%
2 YEAR CAGR
17.14%
5 YEAR CAGR
0.00%
10 YEAR CAGR